• Events
  • Media centre
  • Careers
  • Contact
  • Donate
EORTC
  • Activities
    • Clinical trials
    • Other research initiatives
    • Quality assurance
    • Education & training
    • Early career
    • Public policy
  • Research fields
    • Tumours
    • Cross-discipline
  • Network & partners
    • Members
    • Partners & supporters
    • Government bodies
    • Liaison offices
  • Research tools
    • Study tools
    • Clinical trials database
    • Bibliography
    • Guidelines
    • Data sharing
  • About us
    • Our mission
    • Strategic overview
    • Policies
    • Code of ethical conduct
    • Funding
    • History
    • Governance
    • Headquarters
    • Annual Report
News : 22nd EORTC-NCI-AACR symposium on Molecular targets and Cancer Therapeutics will be held in Berlin, Germany
Abstracts accepted for the 2010 ASCO Annual Meeting
Back to news list
5th EORTC-NCI-ASCO Annual Meeting on “Molecular Markers in Cancer”
News Save the date Uncategorized
Share
  • Linkedin
  • Twitter
  • Facebook

22nd EORTC-NCI-AACR symposium on Molecular targets and Cancer Therapeutics will be held in Berlin, Germany

27 May 2010

http://www.ecco-org.eu/Conferences-and-Events/EORTC-NCI-AACR-2010/page.aspx/1386

Jennifer Crespo

Abstracts accepted for the 2010 ASCO Annual Meeting
Back to news list
5th EORTC-NCI-ASCO Annual Meeting on “Molecular Markers in Cancer”

Related News

Professor John Gordon McVie BSc (Hons), MBChB, M.D., FRCP, FRCPE, FRCPSGlas, FMedSci, DSc (1945-2021)

22 Jan 2021

PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

20 Jan 2021

Webinar: How can current EU policy initiatives pave the way towards treatment optimisation as part of health systems?

14 Jan 2021

Professor John Gordon McVie BSc (Hons), MBChB, M.D., FRCP, FRCPE, FRCPSGlas, FMedSci, DSc (1945-2021)

22 Jan 2021

PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

20 Jan 2021

EORTC lobbies for reducing the economic burden of cancer by optimising treatment for cancer patients

17 Dec 2020

Professor John Gordon McVie BSc (Hons), MBChB, M.D., FRCP, FRCPE, FRCPSGlas, FMedSci, DSc (1945-2021)

22 Jan 2021

PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

20 Jan 2021

Webinar: How can current EU policy initiatives pave the way towards treatment optimisation as part of health systems?

14 Jan 2021
  • Activities
    • Clinical trials
    • Other research initiatives
    • Quality assurance
    • Education & training
    • Early career
    • Public policy
  • Research fields
    • Tumours
    • Cross-discipline
  • Network & partners
    • Members
    • Partners & supporters
    • Government bodies
    • Liaison offices
  • Research tools
    • Study tools
    • Clinical trials database
    • Bibliography
    • Guidelines
    • Data sharing
  • About us
    • Our mission
    • Strategic overview
    • Policies
    • Code of ethical conduct
    • Funding
    • History
    • Governance
    • Headquarters
    • Annual Report
Subscribe to our newsletter Member area Eur. J. Cancer
Follow us on
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • © EORTC
  • Legal notice
  • Privacy Policy
  • HONcode
  • Intranet
  • Password reset
  • Member of European Medical Agency
This website contains cookies to enhance the user experience. More information